Correlation of AKI with risk factors, ventilatory support, renal replacement therapy in a cohort of COVID-19 patients

Conclusions: In our study, AKI prevalence was 6.8%, the need for ventilation was 45.5%, ECMO 0.2%, and the mortality rate 2.9%. Second wave of COVID-19 exhibits improved clinical outcomes compared to the first wave.

Source: Indian Journal of Nephrology - August 4, 2022 Category: Urology & Nephrology Authors: Phanidhar Mogga Shreevidya Venkatraman Urjitha Rajagopalan Prashanth Rajagopalan Prabhu Radhan Kumaresan Maithrayie Sivaraj Padmanabhan Swamikannu Murugan Archana Nagarajan Chandrasekaran Venkataraman Milly Mathew Georgi Abraham Nancy Lesley Source Type: research